iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Amortization of Deferred Charges (2019 - 2025)

Updated

iBio (IBIO) recorded Amortization of Deferred Charges of $120,000 in FY2024 (year ended Jun 30, 2024), down 50.4% from $242,000 in FY2023.

Analysis

iBio (IBIO) Amortization of Deferred Charges (2019 - 2025) Analysis & Trends

  • Per Business Quant data, IBIO's Amortization of Deferred Charges was $242,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 iBio 118.23 Mn -174.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 68,000.00
Jun 30, 2025 68,000.00
Mar 31, 2025 67,000.00
Dec 31, 2024 68,000.00
Sep 30, 2024 68,000.00
Jun 30, 2024 68,000.00
Mar 31, 2024 67,000.00
Dec 31, 2023 68,000.00
Sep 30, 2023 90,000.00
Jun 30, 2023 86,000.00
Mar 31, 2023 68,000.00
Dec 31, 2022 75,000.00
Sep 30, 2022 36,000.00
Jun 30, 2022 12,000.00
Mar 31, 2022 74,000.00
Dec 31, 2021 93,000.00
Sep 30, 2021 416,000.00
Jun 30, 2021 415,000.00
Mar 31, 2021 406,000.00
Dec 31, 2020 415,000.00
API Access

iBio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IBIO&period=max&api_key=YOUR_API_KEY